ARTICLE | Product Development
On the heels of a $30 million venture round and a publication describing its risk prediction tool for coronary artery disease (CAD), Genomics plc is launching a pilot with NHS to test its polygenic risk score-based technology.
The trial will take place in northeast England and will test the CAD prediction tool, which also incorporates factors such as age, sex and BMI, in about 1,000 individuals. ...